AlphAIalphai — Financial news for AI agents
investing.comAUG 252 min read$INTU

After-Hours Movers: INTU, SMTC, SYRE, ZM, NCNO

Intuit (INTU) fell 9% after lowering FY2027 guidance, missing EPS and revenue estimates. Semtech (SMTC) rose 3% on strong Q2 results and raised Q3 outlook. Spyre Therapeutics (SYRE) dropped 16% due to failed clinical trial results. Zoom (ZM) declined 3.5% despite Q2 beat, citing growth normalization. nCino (NCNO) fell 10% on near-term guidance concerns.

Original reporting
investing.com
Published Aug 25, 2026, 8:53 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 8:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$INTU
Bearish
high confidence
Mentioned
$INTU · $SMTC · $SYRE · $ZM · $NCNO
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$INTUBearishHigh
01

Why it matters

Mixed earnings outcomes create sector rotation opportunities.

02

Market read

Earnings and guidance releases drive immediate after‑hours price moves across the listed tickers.

03

What to watch

Intuit's restructuring costs and Zoom's competitive pressures could weigh longer than guidance numbers suggest.

Relevance 8/10Novelty 8/10Timing: after‑hours

Background

Post‑market earnings season with several mid‑cap tech firms releasing guidance.

Company-level read

Ticker impact

$INTUBearishHigh confidence
Context

Intuit shares fell 9% after downbeat FY2027 guidance missing EPS and revenue expectations.

Expected impact

Further downside pressure in near term.

Evidence & confidence

Guidance is materially below consensus and caused a 9% after‑hours drop.

$SMTCBullishHigh confidence
Context

Semtech rose 3% after beating Q2 estimates and raising Q3 guidance well above consensus.

Expected impact

Potential continued rally if AI demand persists.

Evidence & confidence

Quarterly beat and upbeat guidance triggered a price gain.

$SYREBearishHigh confidence
Context

Spyre Therapeutics dropped 16% after its Phase 2 SKYWAY trial failed to meet efficacy thresholds.

Expected impact

Further declines expected pending next trial updates.

Evidence & confidence

Trial failure is a material negative catalyst for a biotech.

$ZMBearishHigh confidence
Context

Zoom fell 3.5% despite a modest Q2 beat and slight FY2027 revenue guidance raise.

Expected impact

Short‑term downside risk remains.

Evidence & confidence

Market reaction shows limited enthusiasm for modest guidance lift.

$NCNOBearishHigh confidence
Context

nCino slipped 10% after Q2 results and near‑flat Q3 revenue outlook missed expectations.

Expected impact

Potential further sell‑off if guidance not revised.

Evidence & confidence

Guidance miss triggered a sharp after‑hours decline.

Market effects

Sector

Tech earnings mix shows divergence; AI‑focused semis like Semtech gain, while consumer‑software firms face pressure.

Regional

U.S. after‑hours market sees mixed moves, modestly influencing broader tech indices.

Global

Limited to U.S. equities; no immediate global macro impact.

Counterpoint

What could challenge this read

Semtech's AI growth could be overhyped; valuation may still be stretched.

Key entities

  • company
    Intuit

    Financial‑software provider

  • company
    Semtech

    Semiconductor supplier

  • company
    Spyre Therapeutics

    Biotech firm

  • company
    Zoom Video Communications

    Video‑conferencing platform

  • company
    nCino

    Cloud banking platform

Read at source← All news

Related articles

AUG 25
$INTUHighAI 9/10

Intuit (INTU) Q4 Earnings and Revenues Top Estimates

Intuit (INTU) reported Q4 earnings of $4.03 per share, beating estimates by $0.44. Revenue was $4.35 billion, up 13.6% year-over-year. The company has exceeded EPS and revenue estimates for four consecutive quarters. Shares are down 44.2% year-to-date. Future stock performance depends on management's earnings call commentary and estimate revisions.

finance.yahoo.com2 min
AUG 25
$INTUMedAI 8/10

Year Sales Guidance Slightly Misses Expectations

Intuit (INTU) reported Q2 CY2026 revenue of $4.35B, up 13.7% YoY, beating estimates. However, its Q3 guidance of $4.31B missed expectations by 1.3%. EPS of $1.34 beat estimates by 75.1%. The company's 5-year revenue growth is 17.4% annually, but recent growth has slowed. Analysts expect 10.4% revenue growth over the next 12 months.

stockstory.org3 min
AUG 25
$INTUMedAI 8/10

INTU Looks 56.8% Undervalued on GF Value™

Intuit Inc (INTU) reported Q4 revenue of $4.4B, beating expectations. GF Value™ estimates INTU's intrinsic value at $826.74, suggesting it is 56.8% undervalued. The company's GF Score™ is 78/100, with strong profitability and growth metrics. Insiders sold $359.2M in shares, while 20 premium gurus hold positions, with 18 adding to their holdings.

gurufocus.com3 min
AUG 25
$ZMMed

Zoom forecasts quarterly profit below estimates

Zoom Communications forecasted third-quarter profit below analysts' expectations, citing competition. Shares fell 3.8% in extended trading. The company expects revenue of $1.275B-$1.28B, below the $1.28B estimate, and adjusted profit of $1.46-$1.48 per share, below the $1.50 estimate. Second-quarter results exceeded expectations with $1.28B revenue and $1.55 adjusted profit per share.

investing.com2 min